498 related articles for article (PubMed ID: 26454613)
41. Long-term patient-rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous integrated boost technique.
Lertbutsayanukul C; Pitak M; Ajchariyasongkram N; Rakkiet N; Seuree F; Prayongrat A
Breast J; 2020 Oct; 26(10):1946-1952. PubMed ID: 32648331
[TBL] [Abstract][Full Text] [Related]
42. Novel 10-fraction breast irradiation in prone and supine position: technical, dosimetric and clinical evaluation.
Guenzi M; Bosetti D; Lamanna G; Siffredi G; Bonzano E; Gusinu M; Garelli S; Pupillo F; Corvò R
Tumori; 2015; 101(2):154-60. PubMed ID: 25838252
[TBL] [Abstract][Full Text] [Related]
43. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.
Guenzi M; Vagge S; Azinwi NC; D'Alonzo A; Belgioia L; Garelli S; Gusinu M; Corvò R
Radiat Oncol; 2010 Nov; 5():111. PubMed ID: 21092219
[TBL] [Abstract][Full Text] [Related]
44. First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.
Dragun AE; Ajkay NJ; Riley EC; Roberts TL; Pan J; Rai SN; Jain D; Quillo AR; Scoggins CR; McMasters KM; Woo SY
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):595-602. PubMed ID: 28581400
[TBL] [Abstract][Full Text] [Related]
45. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
[TBL] [Abstract][Full Text] [Related]
46. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.
Pinnarò P; Soriani A; Landoni V; Giordano C; Papale M; Marsella A; Marucci L; Arcangeli G; Strigari L
J Exp Clin Cancer Res; 2010 Jan; 29(1):9. PubMed ID: 20100335
[TBL] [Abstract][Full Text] [Related]
47. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity.
Deantonio L; Gambaro G; Beldì D; Masini L; Tunesi S; Magnani C; Krengli M
Radiat Oncol; 2010 Nov; 5():112. PubMed ID: 21092288
[TBL] [Abstract][Full Text] [Related]
48. A multi-institutional study of feasibility, implementation, and early clinical results with noninvasive breast brachytherapy for tumor bed boost.
Hamid S; Rocchio K; Arthur D; Vera R; Sha S; Jolly M; Cavanaugh S; Wooten E; Benda R; Greenfield B; Prestidge B; Ackerman S; Kuske R; Quiet C; Snyder M; Wazer DE
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1374-80. PubMed ID: 22209153
[TBL] [Abstract][Full Text] [Related]
49. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
Nozaki M; Kagami Y; Machida R; Nakamura K; Ito Y; Nishimura Y; Teshima T; Saito Y; Nagata Y; Matsumoto Y; Akimoto T; Hiraoka M;
Jpn J Clin Oncol; 2021 May; 51(6):865-872. PubMed ID: 33728450
[TBL] [Abstract][Full Text] [Related]
50. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
51. Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome.
Gatti M; Ponzone R; Bresciani S; Panaia R; Kubatzki F; Maggiorotto F; Di Virgilio MR; Salatino A; Baiotto B; Montemurro F; Stasi M; Gabriele P
Breast; 2013 Dec; 22(6):1136-41. PubMed ID: 23958374
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
53. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
[TBL] [Abstract][Full Text] [Related]
54. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
[TBL] [Abstract][Full Text] [Related]
55. Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.
De Rose F; Fogliata A; Franceschini D; Iftode C; Torrisi R; Masci G; Sagona A; Tinterri C; Testori A; Gatzemeier W; Fernandes B; Rahal D; Cozzi L; Santoro A; Scorsetti M
Br J Radiol; 2018 May; 91(1085):20170634. PubMed ID: 29322827
[TBL] [Abstract][Full Text] [Related]
56. Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity.
Ben Amor R; Bohli M; Naimi Z; Aissaoui D; Mejri N; Yahyaoui J; Hamdoun A; Kochbati L
Strahlenther Onkol; 2023 Jan; 199(1):48-54. PubMed ID: 35943552
[TBL] [Abstract][Full Text] [Related]
57. The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy.
Lansu JT; Essers M; Voogd AC; Luiten EJ; Buijs C; Groenendaal N; Poortmans PM
Eur J Surg Oncol; 2015 Oct; 41(10):1411-6. PubMed ID: 26260375
[TBL] [Abstract][Full Text] [Related]
58. Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer.
De Felice F; Ranalli T; Musio D; Lisi R; Rea F; Caiazzo R; Tombolini V
Breast J; 2017 Sep; 23(5):563-568. PubMed ID: 28252236
[TBL] [Abstract][Full Text] [Related]
59. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.
Olivotto IA; Whelan TJ; Parpia S; Kim DH; Berrang T; Truong PT; Kong I; Cochrane B; Nichol A; Roy I; Germain I; Akra M; Reed M; Fyles A; Trotter T; Perera F; Beckham W; Levine MN; Julian JA
J Clin Oncol; 2013 Nov; 31(32):4038-45. PubMed ID: 23835717
[TBL] [Abstract][Full Text] [Related]
60. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]